Banyan Corp. (BNYN) Stock Price & Analysis
Banyan Corp. (BNYN) closed at USD 0 on Wednesday, October 14, 2026, up 0.00% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 0; the Oct 14, 2026 session ranged USD 0–0 on volume of 5 shares. Market capitalization is $4,544, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, retrieved October 16, 2026 at 06:44 UTC.
Also available as compact Markdown for AI agents: nexqual.com/BNYN.md
Key facts (BNYN)
- Analysts: None.
- Total return with dividends: 1Y +0.0% vs S&P 500 +18.1%; 5Y +90.0% vs S&P 500 +85.1%.
Analysts (BNYN)
Consensus None.
Total return (dividends reinvested) (BNYN)
| 1Y (from 2025-10-16) | 5Y (from 2021-10-11) | |
|---|---|---|
| Total return | +0.0% | +90.0% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +0.0% | +13.7% |
| Volatility (annualized) | 0.0% | 148.1% |
| Max drawdown | +0.0% (→) | -90.0% (Oct 2021→Nov 2021) |
Key Statistics (as of October 16, 2026 at 06:44 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 5 shares |
| Market Cap | $4,544 |
| Exchange | PNK |
Technical Analysis (BNYN)
Nexqual's technical model rates BNYN "STRONG SELL" based on 0 bullish and 5 bearish signals across 126 daily candles, as of October 16, 2026 at 06:44 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (BNYN)
Wall Street analysts rate BNYN "None", per Nexqual as of October 16, 2026 at 06:44 UTC.
| Consensus Rating | None |
|---|
Earnings (BNYN)
Source: Nexqual, October 16, 2026 at 06:44 UTC.
Financials & Fundamentals (BNYN)
| Total Revenue | $3.48M |
|---|---|
| Revenue Growth (latest quarter, YoY) | -48.70% |
| Gross Margin | +100.00% |
| Operating Margin | -27.02% |
| Profit Margin | -114.99% |
| Current Ratio | 0.33 |
| Total Cash | $66,582 |
| Total Debt | $4.36M |
Source: Nexqual, October 16, 2026 at 06:44 UTC.
Financial Health Score (BNYN)
Nexqual rates Banyan Corp.'s overall financial health "Weak" across five dimensions, as of October 16, 2026 at 06:44 UTC.
| Growth | Critical — Revenue -49% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $67K cash vs $4M debt |
| Cash Flow | Weak — Operating cash flow -$163K (TTM) |
| Efficiency | Mixed — No data |
Ownership (BNYN)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 0 |
Source: Nexqual, October 16, 2026 at 06:44 UTC.
Leadership (BNYN)
Banyan Corp. is led by Michael J. Gelmon LL.B. (age 60), Chairman & CEO, per Nexqual as of October 16, 2026 at 06:44 UTC.
| Chairman & CEO | Michael J. Gelmon LL.B. (age 60) |
|---|---|
| President, COO, CFO, Principal Accounting Officer, Chief Legal Officer, Secretary & Director | Cory H. Gelmon (age 65) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| INNV | InnovAge Holding Corp. | USD 8.98 | ▼ 0.44% |
| USPH | U.S. Physical Therapy, Inc. | USD 85.98 | ▲ 0.63% |
| NUTX | Nutex Health Inc. | USD 200.8 | ▼ 1.74% |
| HCSG | Healthcare Services Group, Inc. | USD 21.43 | ▲ 2.58% |
| PNTG | The Pennant Group, Inc. | USD 42.27 | ▲ 5.28% |
| AGL | agilon health, inc. | USD 88.45 | ▲ 2.97% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 06:44 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt